Cobimetinib: observed
5 studies: patients on it are followed, or it is given outside a trial. Page 1 of 1. Open to participants first (1), then studies with results posted, then the rest; newest registration first within each.
- Clinical Outcomes and Biomarkers in Patients With Stage 0-IV Melanoma in Real Clinical PracticeRecruitingNCT05402059Report a problem
- Comparative Effectiveness of Targeted Therapies in BRAF Positive Metastatic Melanoma in the USCompletedNCT05260684Results postedReport a problem
- Comprehensive Analysis of Chemotherapy and Targeted Therapy Outcomes in Recurrent Malignant GliomasActive, not recruitingNCT07448480Report a problem
- Treatment Patterns and Outcomes of Targeted Therapy and Immunotherapy Among BRAF-Positive Melanoma Patients Treated in the Adjuvant Setting and Among BRAF-Positive Metastatic Melanoma Patients With Low Tumor BurdenCompletedNCT05611229Report a problem
- A Study of Adult Participants With BRAF V600 Mutation-Positive Advanced Melanoma Treated With Cobimetinib (Cotellic®) During the French Early Access Program (Temporary Authorization for Use [TAU])CompletedNCT03139513Report a problem